CA2607391A1 — Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent
Assigned to Boehringer Ingelheim International GmbH · Expires 2006-11-02 · 20y expired
What this patent protects
The invention relates to a novel medicament to be inhaled, said medicament containing at least one, preferably one, anticholinergic agent 1 combined with at least one betamimetic agent2 and at least one steroid 3. The invention also relates to a method for producing one such medi…
USPTO Abstract
The invention relates to a novel medicament to be inhaled, said medicament containing at least one, preferably one, anticholinergic agent 1 combined with at least one betamimetic agent2 and at least one steroid 3. The invention also relates to a method for producing one such medicament, and the use thereof for treating respiratory diseases.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.